THE CALIFORNIA STATE UNIVERSITY BAKERSFIELD CHANNEL ISLANDS CHICO DOMINGUEZ HILLS EAST BAY FRESNO FULLERTON HUMBOLDT LONG BEACH LOS ANGELES MARITIME ACADEMY MONTEREY BAY NORTHRIDGE POMONA SACRAMENTO SAN BERNARDINO SAN DIEGO SAN FRANCISCO SAN JOSE SAN LUIS OBISPO SAN MARCOS SONOMA STANISLAUS

Joint Doctoral Program Global Health SDSU-UCSD Graduate School of Public Health Thomas E. Novotny, MD MPH Professor and Co-Director San Diego State University 5500 Campanile Drive San Diego CA 92182-4162 Tel: 619-594-3109 Cell: 619-206-3656 Fax: 619.594.6112

September 8, 2014 David Loy, Legal Director ACLU Foundation of San Diego & Imperial Counties P.O. Box 87131 San Diego, CA 92138-7131 Dear Sir: In response to your query regarding any public health concerns that might be associated with a housing facility for unaccompanied children arriving in the United States, primarily from Guatemala, Honduras & El Salvador, my opinion is that these concerns are insignificant. The infectious diseases that may be present in children from these countries would possibly include tuberculosis (which would be screened, treated, and not much of a problem for kids actually), parasitic diseases (easily screened and managed without risks to others), head lice (common in any kids and easily managed), and hepatitis (again easily detected and managed). These issues would be monitored routinely by our excellent local health department and managed as we do for our non-migrant populations. These children might also be susceptible to vaccine preventable diseases but would likely have received immunizations in their home countries. Of greater concern is the increasing incidence of vaccine refusal among San Diego resident families who falsely believe that vaccines present risks rather than benefits to their children. Failing to immunize presents a significant public health risk to all. I am a former Deputy Assistant HHS Secretary for International and Refugee Health and a 23 year veteran of the US Public Health Service. I currently teach global health in the Graduate School of Public Health, but my opinions are not to be construed as official statements from San Diego State University. I do encourage interested parties to rely on consultations and opinions from our San Diego Department of Public Health regarding any public health concerns in our community. Sincerely yours,

Thomas E. Novotny, MD MPH

1

1

CURRICULUM VITAE THOMAS E. NOVOTNY, M.D., M.P.H.

January 2013 Office Professor and Associate Director for Global and Border Health Graduate School of Public Health

San Diego State University Hardy Tower 119, 5500 Campanile Drive San Diego, CA 92182

OFFICE PHONE: (619) 594-3109

BIRTHDATE: May 3, 1947, Omaha, Nebraska LANGUAGES: Samoan, Spanish EDUCATION: 1969 University of Nebraska, Lincoln B.S. in Zoology

1973 University of Nebraska Medical Center M.D., Accelerated Program

1992 Johns Hopkins University, Bloomberg School Of Public Health M.P.H. in Epidemiology INTERNSHIP: 1973-1974 Highland-Alameda County Hospital, Oakland, CA

RESIDENCY: 1975-1977 Family Practice

University of California, San Francisco The Community Hospital of Sonoma County Santa Rosa, CA

1985-1987 Preventive Medicine

Centers for Disease Control, Atlanta, GA

BOARD CERTIFICATION: Family Practice 1977, Re-certified 1983, 1997 Preventive Medicine 1990

PROFESSIONAL ORGANIZATIONS: Commissioned Officer's Association of USPHS

American Public Health Association, International Section American College of Preventive Medicine Consortium of Universities for Global Health Society for Research on Nicotine and Tobacco Council on Foreign Relations

HONORS: Honors Program, UNL 1965-1969 USPHS Fellowship in Public Health to Yugoslavia 1972 USPHS Citation 1980 USPHS Foreign Service Award 1985 USPHS Citation 1988 USPHS Outstanding Unit Citation 1989 USPHS Commendation 1990

2

2

USPHS Unit Citation 1990 USPHS Unit Citation 1991 USPHS Special Assignment Award 1992

Nominee, Shepherd Award, CDC, 1988 Ralph J. Sachs Visiting Lectureship, UCLA School of Public Health 1992

Delta Omega Honorary Society in Public Health, Alpha Chapter, 1997 Alumnus of the Year, UC San Francisco/Community Hospital of Sonoma County Family Practice Residency Program, 1998 USPH Surgeon General’s Exemplary Service Medal, 2002 Academy of Medical Educators Award for Teaching Excellence, UC San Francisco 2006 Presidents Leadership Award, San Diego State University, 2010 Presidents ‘Top 25’ Selection, San Diego State University, 2010 Graduate Professor of the Year, College of Health and Human Services, SDSU 2011 Fulbright Senior Specialist, 2004, 2011 Outstanding International Scholar, Scholars Without Borders SDSU 2012 PROFESSIONAL EXPERIENCE: 1/15/09-Present Professor and Associate Director for Global and Border Health San Diego State University, Graduate School of Public Health Co-director, Joint PhD Program (JDP) in Global Health Chair, International Health Committee Adjunct Professor, Family and Preventive Medicine, Division of Global Health University of California, San Diego Duties: Leadership of new JDP in Global Health. Developed three new courses (Global Health I and II, Program Planning and Evaluation, and Doctoral Seminar). Developed new seminar series on Global Health, sponsored Regional CDC Epidemic Intelligence Service Conference at SDSU, implemented CDC-funded Health Diplomacy Training Initiative (held Nov 2, 2009 in Washington DC), invited speaker World Affairs Council 2009 webcast on Global Health, founding member of Global Health Diplomacy Consortium, won Presidents Leadership Fund Award to develop Field Placement Program for Global Health JDPs. Initiated Book Series on Global Health Diplomacy.

Research program includes analysis of factors leading to initiation of smoking among Young Chinese women, feasibility of smoking cessation in DOTS TB clinics in multiple International settings, establishing toxicity of environmental waste due to discarded Cigarette butts, and health diplomacy. 4/1/04-12/31/08: Professor in Residence, Epidemiology and Biostatistics University of California, San Francisco

Duties: Provided leadership in developing academic linkages, student educational experiences, curricula in global health, and global health research opportunities for faculty and students. Developed curricula in global health, clinical research, and tobacco control. Assisted in supervision of Preventive Medicine Residency Program. Represented the UCSF campus on various international educational committees and UC system-wide committees (IGCC, Senior International Education Council). Research program included HIV/AIDS in Eastern Europe, tobacco control, health systems reform, bioethics and globalization, and non-communicable diseases.

3

3

10/1/02-3/31/04 Education Coordinator, UCSF Global Health Sciences University of California, San Francisco Teaching: Global Health, Health Policy, Intro to Global Health, Developed Area of Concentration in Global Health for medical students Developed a new MS degree program in Global Health Sciences Developed Certificate Program in Global Health for Sandwich scholars from abroad 10/1/02- 5/31/04: Visiting Professor, University of California, San Francisco Institute for Global Health, Department of Epidemiology and Biostatistics 2/1/02-Present: Public Health Consultant, World Bank, (Latvia Serbia, Albania, Croatia, Romania, Bulgaria, Macedonia, Russia, Barbados, Brazil), HIV/AIDS, Public Health Systems, Chronic Disease Control 7/1/99- 2/1/02: Active Duty Commissioned Officer, USPHS Assistant Surgeon General (Rear Admiral)

Deputy Assistant Secretary for International and Refugee Health, Director, Office of International and Refugee Health

Duties: Provided leadership in global health from the Office of the Surgeon General. Oversaw linkage with operative divisions of DHHS and represented US Government on World Health Organization Executive Board, PAHO Directing Council, and WPRO meetings. Participated as delegate to World Health Assembly for three years. Responsible for managing multi-lateral and bilateral partner activities in global health, directing the Office of International and Refugee Health, supporting the Secretary and Assistant Secretary in policy development, negotiations, and meetings with international officials. Developed global health strategy for DHHS in partnership with Department of State, AID, National Security Council, and other key USG agencies. Chaired International Policy Advisory Council for Multilateral Organizations.

1997- 1999: Active Duty Commissioned Officer, USPHS CDC Liaison to the World Bank

Duties: Leadership role as technical expert and principal liaison between the Centers for Disease Control and Prevention and the World Bank. Member of CDC Office of Global Health Senior Management Team and consultant to missions of the World Bank in East Asia, Eastern Europe, Central Asia, Latin America, and the Caribbean. Contributor to World Bank publications on the Economics of Tobacco Control in Developing Countries, and on HIV/AIDS in Central Asia, Southeastern Europe, and Western Balkans.

1997-Present: Senior Associate, Department of International Health, Johns Hopkins University School of Hygiene and Public Health

1992-1997: Assistant Dean for Public Health Practice CDC Liaison Officer to UC Berkeley

Public Health Practice Program Office Centers for Disease Control and Prevention

Adjunct Professor and Program Head, Interdisciplinary MPH UC Berkeley School of Public Health

Duties: Program development and administration in public health practice; curriculum

4

4

development, supervision of doctoral and master's student research; original research in tobacco control and public health practice, developing linkages between state, local, and community-based health agencies and the university; representation of CDC in national organizations and at international scientific meetings. Developed series of special issues of American Journal of Preventive Medicine on Research Linkages Between Academia and Practice. Program Head, Interdisciplinary MPH program.

1995-98: Family Physician

Family Health Centers of Solano County Duties: Providing primary care to underserved populations in Northern California County-wide HMO.

1991-1992 Special Assignment to the Pan American

Health Organization Washington, D.C. Duties: Report on Smoking and Health in the Americas; management of a major international research, planning, and publishing project involving 35 countries, 6 regional representatives, and more than 60 writers, consultants, reviewers, and editors. Published two-volume report in 1992; presented data at and conducted 8 international workshops on smoking, cancer, and tobacco control international policy.

1987-1991 Office on Smoking and Health Centers for Disease Control Rockville, Maryland Chief, Program Services Activity

Duties: Managing Editor, Surgeon General's Report on the Health Consequences of Smoking: Nicotine Addiction, 1988; Scientific Editor, Surgeon General's Report, Reducing the Health Consequences of Smoking: 25 Years of Progress, 1989; Senior Editor, PAHO/Surgeon General's Report on Smoking in the Americas, 1992; developed software to estimate economic costs of smoking; supported program development in 50 states and international settings; planned, conducted, and supervised epidemiologic analyses, surveys, and studies. 1988-1991 Family Physician

Hayfield Medical Center Alexandria, VA

Duties: Provided primary care.

1986-1987 Preventive Medicine Resident Center for Health Promotion and Education, Behavioral Epidemiology and Evaluation Branch Centers for Disease Control Atlanta, Georgia

Duties: Conducted epidemiological analyses of large national and state data sets on tobacco and health and other behavioral risk factors.

1984-1986 Epidemic Intelligence Service Officer

Centers for Disease Control Field Services Division Denver, Colorado

Duties: Conducted epidemiologic studies including outbreak investigation, chronic diseases, and vaccine preventable diseases; planned and supervised research into HIV in drug addicts; participated in policy development at state level on HIV testing and reporting, outbreak management of measles among groups religiously exempted from

5

5

immunizations, and tobacco control.

1984-1986 Asst. Clinical Professor Preventive Medicine University of Colorado Health Sciences Center Denver, Colorado

Duties: Planned and conducted curriculum in preventive medicine at the University of Colorado Medical Center.

1979-1984 Family Physician and Clinic Director

Russian River Health Center (NHSC) Guerneville, California

Duties: Full range of primary care to a Federally Qualified Health Manpower Shortage Area; supervised 13-person clinic staff, residents, medical students, and mid-level practitioners; conducted continuing education classes for professionals at several levels; budget, personnel management, and program planning. 1977-1984 Clinical Assistant Professor

UCSF Dept of Family and Community Medicine Santa Rosa, California 1977-1979 Emergency Room Director

Community Hospital Santa Rosa, California

Duties: Supervised full-service emergency room -- physicians, nurses, paramedics; conducted Advanced Cardiac and Trauma Life Support classes; EMS planning with County.

1977-1978 Emergency Physician

Highland Hospital Oakland, California

1978-1979 Emergency Physician

San Francisco General Hospital San Francisco, California

1975-1980 Staff Physician

Sonoma Co. Maternal Outreach Project

1975-1977 Staff Physician Indian Health Center Santa Rosa, California

1977 Ob-Gyn Staff Assistant

Highland Hospital Oakland, California

BOARDS, ADVISORY GROUPS, AND SERVICE ACTIVITIES

2011-present President and CEO of the Cigarette Butt Pollution Project (501c3) 2012-present SDSU Scholars Without Borders Advisory Committee 2009-present Advisory committee, UC San Francisco Center for Tobacco Control

research and Education 2010-2011 Co-chair for Domain 6, “Socio-cultural and Political Awareness,” of the

6

6

Global Health Core Competency Development Project, Association of Schools of Public Health

2009-2011 Global Health and U.S. Health Diplomacy Working Group of the Commission on U.S. Federal Leadership in Health and Medicine at the Center for the Study of the Presidency and Congress.

Washington, D.C. 2009-present San Diego State University

Steering Committee, Joint Doctoral Program Co- Director, Joint Doctoral Program in Global Health Chair, International Health Committee, GSPH

2002-2008 UC San Francisco Research Subcommittee, Program in Population Sciences and Global Health

Education Subcommittee, Program in Population Sciences and Global Health Curricular Innovations Project Area of Concentration in Global Health, Lead Faculty UC System-wide Council on International Education UC System-wide Institute for Global Conflict and Cooperation Steering Committee Member Faculty Council of the Academic Senate

1984-present American Public Health Association 1. International Human Rights Committee 2. Participant in APHA strategic planning process (2001) 3. Organized concurrent session on Global Health for 2001

APHA Meeting (Atlanta) 4. Past member of Epidemiology Section and ATOD section, and

now International Health Section 5. Special Session APHA Annual Meeting 2009

American College of Preventive Medicine 1. PM Residency Directors group 1992-2008 2. Editor of ACPM three Supplements on “Research Linkages

Between Academia and Practice, 1994-1997 3. American Journal of Preventive Medicine Editorial Board

1994-2006 2006-present European Journal of Public Health Editorial Board 2003-present PLoS Medicine Editorial Board

1992-present Tobacco Control: An International Journal, Editorial Board 2001-2007 Johns Hopkins Bloomberg School of Public Health

Dean’s Alumni Advisory Council 1998-99 Health Promotion and Education Applications’ Editorial Board 1996-97 CDC representative to the ASPH Council on Linkages 1994-97 Member, ASPH Council of Public Health Practice Coordinators 1993-1995 Asian Health Services, Oakland, CA, Volunteer Physician 1989-1994 California Department of Health Services, Tobacco Evaluation

Advisory Committee 1987-1989 CDC Representative, PHS Interagency Committee on Quality

Assurance and Risk Management 1992-1997 UC Berkeley Wellness Letter, Editorial Board 1993-1997 UC Berkeley Prevention Center, Management Team

1993-1997 Oakland Community-Based Public Health Initiative: Community Health

Academy's Executive Board

7

7

1993-1994 UCSF/UC Berkeley Joint Medical Program Admissions Committee, Panel 5

2002-2008 Lakeside Property Owner’s Association, Board Member and President INTERNATIONAL EXPERIENCE: 1969-1970 Western Samoa

Sanitarian, U.S. Peace Corps 1972 Fareham, England Psychiatry Elective 1977 Edinburgh, Scotland Rheumatology Elective

1972 Zagreb, Yugoslavia USPHS Fellowship--Andrija Stampar School of Public Health 1977 Guatemala

Clinic Director, Earthquake Relief 1978 Nepal

Trek Physician l980 Micronesia

U.S. Department of Energy Field Trip to Kili Island to evaluate Bikini Atoll refugees

l985 Ethiopia Refugee Health, USAID Mission

l987 Puerto Rico Consultant to Territorial Health Department

l987 Tokyo, Japan Sixth World Conference on Smoking and Health

1987 People's Republic of China World Bank Consultant to Ministry of Health

1989 Bolivia Preparatory work, PAHO/Surgeon General’s

Report on Smoking in the Americas 1989 Geneva, Switzerland

Consultancy on the calculation of world-wide smoking-attributable mortality

1990 Bombay, India Tata Institute of Fundamental Research Invited Speaker, “International Symposium on the Control of Tobacco”

1990 Caracas, Venezuela PAHO/Surgeon General’s Report

1990, 1991 Port of Spain, Trinidad and Tobago Caribbean Area Epidemiology Centre

PAHO/Surgeon General’s Report 1991 Quito, Ecuador

Invited speaker, "Tobacco Trends and Cancer" International Congress of Cancer Registries

1992 Buenos Aires, Argentina Invited speaker, “Tobacco or Health: Status in the Americas” Eighth World Conference on Tobacco and Health

1993 Reykjavik, Iceland Invited speaker, "Tobacco, alcohol, and

lifestyle factors in cancer causation”

8

8

Ninth Congress on Circumpolar Health 1993 Harare, Zimbabwe

Invited speaker, "The Public Health Practice of Tobacco Control: an Integrated Approach" All Africa Conference on Tobacco Control

1993 Johannesburg,Capetown, Republic of South Africa Invited presenter, “Workshops on Local Tobacco Control”

1994 Kiev, Ukraine Consultant to the World Bank on the establishment of school of public health

1994 Rio de Janeiro, Brazil Keynote speaker for the First Brazilian Conference on Tobacco Control

1994 Paris, France Invited speaker, Ninth World Conference on Tobacco and Health

1995 Salvador, Bahia, Brazil Invited Speaker

Brazilian/Latin American Epidemiology Conference 1996 Pitcairn Island, South Pacific

Volunteer Physician, 1996 Porto, Portugal Invited Speaker

First Portuguese Epidemiology Congress 1997 China, Pre-identification and Identification Missions for Health IX: HIV and MCH 1997 Azerbaijan, Identification Mission Health Reform Project 1997-1999 Hungary Health Services and Management Project World Bank Lead Public Health Consultant 1998 Capetown, South Africa Invited Speaker, Economics of Tobacco Control 1998-99 Republic of Georgia World Bank Lead Public Health Consultant 1996 Armenia

Public Health Consultant 1997 Croatia

World Bank Lead Public Health Consultant 1998 Invited Speaker, Project Coordination Unit Conference, East Europe

and Central Asia Region, Talinn, Estonia: From Actions to Deeds. 1998 Invited Speaker, Warsaw, Poland: “Health Transitions in Eastern

Europe.” Tobacco Control Workshop. 1999 World Bank: Consultant in Public Health: Poland

Croatia, Latvia, Estonia, Georgia, Hungary. Invited Speaker, 1999 Project Management Unit Conference: “Economics of Tobacco Control” and “Choosing and Financing Public Health Options”; visitors program, North Karelia CVD Prevention Project, Finland;

1999 WHO: Alternate Delegate to World Health Assembly, Geneva; PAHO Directing Council, San Juan, Puerto Rico; WIPRO Meeting, Macau (observer);

WHO Geneva: Head of US Delegation, Framework Convention on Tobacco Control (FCTC) Working Group and Negotiating Body, Geneva;

2000 WHO: Executive Board Member Representing the US;

9

9

Alternate Delegate to World Health Assembly, Geneva; Head of Delegation, FCTC Negotiating Body, Geneva 9th US-Russia Bilateral Health Committee Meeting, Moscow World Federation of Public Health Associations Invited Speaker, Beijing Site Visit, US Embassy and Ministry of Health and Welfare Hanoi World Bank: Project Completion Report mission, Hungary Health Project, Budapest Supervision missions, Latvia Health Project, Riga Invited Speaker, World Conference of Public Health Associations, “Public Health and Health Reform”, Beijing, China

2001 WHO: Alternate Delegate to World Health Assembly; Member of Executive Board; Head of Delegation, FCTC Negotiating Body, Geneva Observer, WPRO meeting, Brunei World Bank: Mid-term review, Latvia Health Project, Riga Keynote Speaker, Launch of SALUD URUGUAY Montevideo, Uruguay Consultation, Ministry of Health Santiago, Chile

2002 World Bank consultant: Serbia, Latvia Health Projects Research: Averting the AIDS Crisis in Eastern Europe

2002 London School of Hygiene and Tropical Medicine Honorary Researcher World Bank Consultant in Serbia, Latvia, Hungary

2003 World Bank consultant: Serbia, Russia, Southeastern Europe Central Asia. Research Project under London School of Economics: “Bioethical Implications of Globalization”

2004 World Bank consultant: Baltics project to model HIV and TB CDC Serbia project to conduct behavioral surveillance in hard to reach populations (with Imperial College, London)

2005 World Bank Central Asia Project to develop surveillance system for HIV/AIDs Croatia: Scientific writing course, collaborative project under Oxford Vision 2020 to develop non-communicable disease control project. Invited Speaker, Global Health Education Consortium, Toronto, Canada

2006 Northern Ireland: International Harm Reduction Conference Presentation Research on HIV/AIDS Estonia, Latvia, Lithuania Invited Speaker: European Commission, Brussels: Bioethical Implications of Globalization Croatia: Course on Clinical Research Training

2007 Consultation to Macedonia on Public Health System Reform (World Bank) Graduate Institute of International and Development Studies, Geneva: course on Global Health Diplomacy (Fulbright Senior Specialist Grant) Invited Speaker, Global Health Education Consoritum Annual Meeting Dominican Republic

10

10

Society for Nicotine and Tobacco Research (Poster), Rio de Janeiro Medical Education Consortium with Cuba Research Trip, Cuba

2008 Research project on TB and smoking cessation, Rio de Janeiro Consultation to Macedonian MOH, Public Health System Reform Consultation to Barbados National AIDS Commission: Prevention Plan development Cuba Health Diplomacy and Medical Education Research Project (Atlantic Philanthropies) Graduate Institute of International and Development Studies, Geneva: course on Global Health Diplomacy

2009 World Conference on Tobacco or Health, Mumbai Participant and speaker, Prince Mahidol Conference on Global Health Bangkok, Thailand Consultant, World Bank HIV AIDS Prevention Project, Barbados Research Collaboration, Federal University of Rio de Janeiro “Smoking Cessation in TB DOTS Clinics”

Participant and Speaker, Rockefeller-Bellagio Network on Global Health Diplomacy, Bellagio, Italy

2010 NIH-Chinese Academy of Sciences Research Collaboration Meeting, Guangzhou, China (invited speaker) Research collaboration, Chinese Centers for Disease Control, “Smoking Initiation Among Young Chinese Women” “Smoking Cessation in TB DOTS Clinics” World Bank, Consultation on HIV/AIDS Prevention Program, Barbados Participant, Rockefeller-Bellagio Network on Global Health Diplomacy Bellagio, Italy Research Project, Smoking Cessation in TB DOTS Clinics, Rio de Janeiro, Brazil Training in Global Health Diplomacy, CDC, Nairobi, Kenya, 2011 Fulbright Senior Specialist, Federal University of Rio de Janeiro, Brazil

Research (June and December) Research collaboration, Chinese Centers for Disease Control, “Smoking Initiation Among Young Chinese Women” Global Health Diplomacy Conference, Chatham House, London World Bank, Consultation on HIV/AIDS Prevention Program, Barbados World Bank Consultation, Lessons Learned on HIV/AIDS in LAC Global Heath Diplomacy Presentation, National Inst. Public Health Cuernavaca, Mexico World Lung Conference, Workshop on TB and Smoking, Lille, France Training in Global Health Diplomacy, Nairobi, Kenya

2012 Singapore World Conference on Tobacco Or Health, Speaker Rio de Janeiro: Developed Undergrad Course for SDSU students

PUBLICATIONS: l. Novotny T, Judson L, McAnnich J, Scott JO. Genitourinary System, in O'Hara-Devereaux

(ed). Eldercare: A Guide to Clinical Geriatrics. New York: Grune and Stratton, l98l. 2. Novotny T., Vaginal disease: Venereal and nonvenereal types. Postgrad Med

l983:73:303-3l2.

11

11

3. USPHS. Lead exposure in families of workers for a capacitor and resistor manufacturing plant, Grand Junction, Colorado. EPI 84-85-2. August 9, l985.

4. Istre GR, Compton R, Novotny T, et al. Infant botulism: three cases in a small town. AJDC

l986;l40:l0l3-l0l4. 5. Kaye WE, Novotny TE, Tucker M. New ceramics-related industry implicated in elevated

blood lead in children, Arch Env Health l987; 42:l6l-l64. 6. Novotny TE. Book Review: Current Medicine, Gitlick G.(ed). Postgrad Med l983:73. 7. CDC. Lead poisoning in a capacitor and resistor plant--Colorado. MMWR l985; 34:384-5. 8. CDC. Measles in a population with religious exemption to vaccination--Colorado. MMWR

l985,34:7l8-20. 9. CDC. Smoking prevalence and cessation in selected states, l981-l983 and l985--The

Behavioral Risk Factor Survey. MMWR l986; 35:740-3. l0. Novotny TE, Cook LA, Hughes D, Lee SA. Lead exposure in a firing range. Am J Public

Health l987;77:l225-26. ll. Novotny TE. Book Review: The History of Health and Sickness in America, Leavitt and

Numbers(ed). JAMA l987;257:283l-2. l2. USPHS. Smoking-attributable mortality, morbidity, and economic costs in San Juan, Puerto

Rico. EPI-87-37-2, March 17, 1987. l3. Novotny TE, Jennings CE, Doran M, et al. Measles epidemics in religiously exempt groups:

A report of two outbreaks. Pub Health Rep l988;l03:49-54. l4. Novotny T, Dingman J, Pavia, A. Foodborne illness associated with a pig roast. Jour Food

Protect l987;50:945-947. l5. CDC. Smokeless tobacco use in the United States--Behavioral Risk Factor Surveillance

System, l986. MMWR l987;36:337-340. l6. Novotny TE, Shillam PS, Janoff EN, Hopkins RS. Prevalence of Giardia lamblia and risk

factors for infection among children attending day-care facilities in Denver. Pub Health Rep 1990;105(1):72-75.

l7. Novotny TE, Warner KE, Kendrick JS, Remington PM. Socioeconomic factors and racial

smoking differences. Am J Public Health 1988; 78:ll87-ll89. l8. Remington PL, Novotny TE, Anda RM, Williamson DR. State progress toward the l990

objectives for the nation cigarette smoking prevalence. Am J Public Health 1989;79:1416-1419.

l9. Novotny TE, et al. Socioeconomic factors and racial smoking differences. In Aoki M,

Hisamichi S, and Tominaga S (ed). Smoking and Health l987, Proceedings of the Sixth World Congress on Smoking and Health, Elsevier, Amsterdam, l988, pp 703-706.

20. Novotny TE, et al. Smokeless tobacco use in the United States. In Aoki M, Hisamichi S, and

12

12

Tominaga S (ed). Smoking and Health l987, Proceedings of the Sixth World Congress on Smoking and Health, Elsevier, Amsterdam, l988, pp 879-882.

21. Novotny TE, et al. Passive smoking: Attitudes and exposure in The United States. In Aoki M,

Hisamichi S, and Tominaga S (ed). Smoking and Health l987, Proceedings of the Sixth World Congress on Smoking and Health, Elsevier, Amsterdam, l988, pp 259-262.

22. CDC. Smoking-attributable mortality and years of potential life lost--United States, l984.

MMWR l987; 36:694-697. 23. CDC. Passive smoking: Attitudes and exposure in the United States. MMWR l988;

37:239-24l. 24. Novotny TE and Peto R. Estimates of future adverse health effects of smoking in China. Pub

Health Rep l988;l03:552-553. 25. Novotny TE. Cessation of smoking and the social millieu. (Editorial) Mayo Clin Proc

l988;63:729-73l. 26. Novotny TE, Pierce JP, Fiore MC, and Davis RM. Smokeless tobacco use in the United

States: The Adult Use of Tobacco Surveys. NCI Monograph 8:25-28, 1989. 27. Davis RM, Novotny TE. The epidemiology of cigarette smoking and its impact on chronic

obstructive pulmonary disease. Am Review Respir Dis 1989;14:S82-S84. 28. CDC. State-specific estimates of smoking-attributable mortality and years-of-potential life

lost. MMWR l988;37:689-693. 29. Fiore MC, Novotny TE, Pierce JP et al. Trends in cigarette smoking in the United States:

The changing influence of gender and race. JAMA l989;26l:49-55. 30. Hatziandreu EJ, Pierce JP, Fiore MC, Grise V, Novotny TE, and Davis RM. The reliability of

cigarette consumption in the United States. Am J Public Health 1989;79:1020-1023. 3l. Pierce JP, Fiore MC, Novotny TE et al. Trends in smoking in the United States: Educational

differences are increasing. JAMA l989;26l:56-60. 32. Janoff EN, Kraft JC, Pickering LK, Novotny TE et al. Diagnosis of Giardia lamblia infections

by detection of parasite-specific antigen. J Clin Microbiol 1989;27:431-435. 33. Pierce JP, Fiore MC, Novotny TE et al. Trends in cigarette smoking in the United States:

Projections to the year 2000. JAMA l989;26l:56-60. 34. Goldbaum GM, Ostroff SM, Novotny TE. The costs of smoking for Washington State.

Washington Public Health l989; 7(1):37-38. 35. Breukelman FN, Zeitz, PS, and Novotny TE. Smoking in Delaware: Economic costs and

deaths attributable to cigarette smoking in the State, l985. Delaware Medical Journal l988;60:735-740.

36. Novotny TE. Smoking policies and the healthy worker effect. Southern Med Jour (editorial)

1990;83(1):11-12.

13

13

37. CDC. Trends in lung cancer incidence--United States, 1973-1986. MMWR 1989;38:505-513. 38. CDC. State-specific smoking-attributable chronic obstructive pulmonary disease

mortality--United States, 1986. MMWR 1989;38:552-561. 39. CDC. State-based chronic disease control. The Rocky Mountain Tobacco-Free Challenge.

MMWR 1989; 38:(44)749-752. 40. Novotny TE, Fiore MC, Hatziandreu E, Giovino GA, Mills SL, Pierce JP. Trends in smoking

by age and sex, United States, 1974-1987: the implications for disease impact. Prev Med 1990;19:552-561.

41. Hatziandreu, EJ, Pierce JP, Lefkopoulou M, Fiore MC, Mills SL, Giovino GA, Novotny TE.

Quitting smoking in the United States in 1986. J Natl Cancer Inst 1990;2:1402-6. 42. Fiore MC, Novotny TE, Pierce JP, Giovino GA et al. Methods used to quit smoking in the

United States: do cessation programs help? JAMA 1990;263(20):2760-2765. 43. CDC. State tobacco-use prevention and control plans. MMWR 1990;39(8):133-136. 44. USDHHS. Smoking-attributable mortality, years of potential life lost, and economic

impact--State-specific estimates, 1985. In Smoking and Health: A National Status Report, 2nd Edition. U.S. Department of Health and Human Services, Public Health Service, Office on Smoking and Health. DHHS publication No. (CDC) 87-8397.

45. CDC. Employee smoking policy--Colorado. MMWR 1990;39(38):673-676. 46. CDC. Smoking-attributable mortality--Kentucky. MMWR 1990;39(38):680-683. 47. CDC. Trends in lung cancer incidence and mortality--United States, 1980-1987. MMWR

1990(39):875-883. 48. Novotny TE, Thomas WI. Rocky Mountain Tobacco-Free Challenge Evaluation Report.

Office on Smoking and Health, 1989, 1990. 49. CDC. State coalitions for prevention and control of tobacco use. MMWR 1990;39(28):476-

485. 50. CDC. Cigarette sales to minors--Colorado, 1989. MMWR 1990;39(44):794-801. 51. Lanier AP, Bulkow LR, Novotny TE, Giovino GA, Davis RM. Tobacco use and its

consequences in northern populations. Arct Med Res 1990;49:17-22. 52. Dietz VJ, Novotny TE, Rigau-Perez JG, Shultz JM. Smoking-attributable mortality, years of

potential life lost, and direct health care costs for Puerto Rico, 1983. Bulletin of PAHO 1991;25:77-86.

53. Shultz JM, Novotny TE, Rice DP. Quantifying the disease impact of cigarette smoking with

SAMMEC II software. Public Health Rep 1991;106:326-332. 54. Smoking-attributable mortality and YPLL--U.S., 1988. MMWR 1991;40:62-71. 55. Novotny TE. Passive smoking: beliefs and attitudes in the United States. EPA Technical

14

14

Compendium on Environmental Tobacco Smoke, 1991. 56. CDC. World No-Tobacco Day, 1991. MMWR 1991;40:341-342. 57. Choi WS, Novotny TE, Thimis AT. Restricting minors' access to tobacco--a review of State

legislation, 1990. Am J Prev Med 1992;8:19-22 58. Choi WS, Novotny TE, Davis RM, Epstein J. State tobacco prevention and control activities:

results of the 1989-1990 Association of State and Territorial Health Officials (ASTHO) Survey Final Report. MMWR Reports and Recommendations 1991;40(RR-11):1-28.

59. Novotny TE, Romano RA, Davis RM, Mills SL. The public health practice of tobacco control:

lessons learned and directions for the States in the 1990s. Ann Rev Public Health 1992;13:287-318.

60. Emmons KM, Abrams DB, Marshall R, Etzel RA, Novotny TE, Marcus BH, Kane M. Exposure

to environmental tobacco smoke in naturalistic settings. Am J Public Health 1992;82(1):24-26.

61. Marcus BH, Marshall RJ, Kane M, Novotny TE, Etzel RA. Restrictive workplace smoking policies: impact on nonsmokers' tobacco exposure. Journal of Public Health Policy 1992;13(1):42-51.

62. Emont SL, Choi WS, Novotny TE, Giovino GA. Clean indoor air legislation, taxation, and smoking behaviour in the United States: an ecological analysis. Tobacco Control 1992;2:13-17.

63. Novotny TE (Senior Editor) et al. Tobacco or Health: Status in the Americas, 1992.

Washington DC: Pan American Health Organization, Scientific Publication No. 536, 1992. 64. Novotny TE, Nicholls E, Restrepo H. Tobacco or health: status in the Americas, 1992. Bull

PAHO 1992;26(2):192-199. 65. Marcus SE. Pierce JP, Giovino GA, Kleinman JC, Novotny TE. Regional trends in cigarette

smoking behaviour in the United States. Tobacco Control 1992; 1:107-113. 66. Novotny TE. Tobacco use and its consequences. In, Brownson, RC, Remington PL, Davis

JR. (eds.), Chronic Disease Epidemiology and Control. Washington DC: American Public Health Association; 1993.

67. Brownson RC, Novotny TE, Perry MC. Cigarette smoking and adult leukemia: a meta-

analysis. Arch Int Med 1993;153:469-475. 68. Nelson DE, Lawton RL, Giovino GA, Eriksen MP, Novotny TE. Correspondence re: B.

Wagner. "The 'cause of death' is dying." Editorial. Mod Pathol 6:237, 1993. 69. Novotny TE. (Book Review) Report of the Royal College of Physicians: Smoking and the

Young. Tobacco Control 1992;1(4):308. 70. Novotny TE. The public health practice of tobacco control. In, Gupta PC, Hammer JE, Murti

PR (eds.). Control of Tobacco-Related Cancers and Other Diseases. Proceedings of an International Symposium, January 15-19, 1990, Tata Institute for Fundamental Research. Bombay, Oxford University Press, 1992.

15

15

71. Novotny TE, Nicholls E, Restrepo H. Tabaco o salud: situacion en las Americas (Informe

especial). Boletin de la Oficina Sanitaria Panamericana. 1992:113(4):281-289. 72. Novotny TE, Shane P, Daynard R, Connolly GN. Tobacco use as a sociologic carcinogen:

The case for a public health approach. In, DeVita VT (ed.), Cancer Prevention. Philadelphia PA: J.B. Lippencott Company; June 1993.

73. CDC. Medical-care expenditures attributable to cigarette smoking--United States, 1993.

MMWR 1994;43:469-472. 74. Novotny TE. The public health practice of tobacco control: an integrated approach.

Proceedings, All Africa Conference on Tobacco Control, Harare, Zimbabwe, November 15-19, 1993. Johannesburg: Essential Health Research Group of the Medical Research Council, Republic of South Africa, 1994.

75. Emmons KM, Abrams DB, Marshall R, Marcus BH, Kane M, Novotny TE, Etzel RA. An

evaluation of the relationship between self-report and biochemical measures of environmental tobacco smoke exposure. Prev Med 1994;23:35-39.

76. Novotny TE. Nosology and epidemiology--dance partners in tobacco control (Editorial).

Tobacco Control 1994;3:95-6. 77. Novotny TE. Tobacco, taxes, and tough choices. Sonoma County Physician 1994;

September-October:8-9. 78. Berman SJ, Perkocha VA, Novotny TE. A continuing education preference survey of public

health graduates. Am J Prev Med 1995;11:19-25. 79. Novotny TE, and Healton CL. A symposium on research linkages between academia and

practice (Editorial). Am J Prev Med 1995;11(suppl):1. 80. Perkocha V, Novotny TE, Bradley J, Swanson J. The efficacy of two comprehensive perinatal

programs on reducing adverse perinatal outcomes. Am J Prev Med 1995;11(suppl):21-9. 81. Novotny TE, et al. Medical care expenditures attributable to cigarette smoking: United States,

1993. In, Proceedings of the 9th World Conference on Tobacco and Health. New York, NY:Plenum Publishing Corporation, 1995. pp 315-8.

82. Brownson RC, Koffman DM, Novotny TE, et al. Environmental and policy interventions to

control tobacco use and prevent cardiovascular disease. Health Ed Q 1995;22(4)478-98. 83. Warner KE, Chaloupka FJ, Cook PH, Manning WG, Newhouse JP, Novotny TE, Schelling

TC, Townsend. Criteria for determining an optimal cigarette tax: the economists perspective. Tobacco Control 1995;4(4):380-386.

84. Novotny TE, Siegel MB. California's Tobacco Control Saga. Health Affairs 1996;15(1):58-72. 85. Longo DR, Brownson RC, Johnson JC, Hewett JE, Kruse RL, Novotny TE, Logan RA.

Hospital smoking bans and employee smoking behavior-results of a national survey. JAMA 1996;275:1252-1257.

86. Novotny TE, Nitzkin JL. Bridge over troubled waters. Am J Prev Med

16

16

(editorial)1996;Supplement to Volume 12;1-2. 87. Novotny TE, Nitzkin JL, Guest Editors. Research Linkages Between Academia and Public

Health Practice, 1996. Am J Prev Med Supplement to Volume 12, No. 4, July /August 1996 88. Novotny TE (editorial). Smoking among Black and White Youth: Differences that Matter. Ann

Epidemiol 1996;6:474-475. 89. Novotny TE, Miller LS, Flint AJ, Longo DR, Giovino GA. The epidemiology of tobacco use and

its health consequences: recent studies on economics, behavior, and policies in the United States.Revista de Epidemiologia, Suplemento de Arquivos de Medicina (Portugal) 1997;2:3-7.

90. Moskowitz JM, Shane PA, Novotny TE. Tobacco and Alcohol Surveillance Systems for Youth

in the United States. Final Report Submitted to the Robert Wood Johnson Foundation, May 2, 1996. Center for Family and Community Health, School of Public Health, University of California, Berkeley, 1996.

91. Flint AJ, Novotny TE. Poverty status and trends in smoking prevalence and cessation in the

United States, 1983-1993: the independent risk of being poor. Tob Control 1997;6:14-18. 92. Novotny TE, Loe H, Tilson H, et al. Publishing while practicing: a five-step guide for academic

practice partners. Am J Prev Med 1997;13 (suppl):10-11. 93. Miller LS, Zhang X, Novotny T, Rice DP, Max W. State estimates of Medicaid expenditures

attributable to cigarette smoking, Fiscal Year 1993. Public Health Rep 1998; 113:140-51. 94. Wismer BA, Moskowitz JM, Chen AM, Kang SH, Novotny TE, et al. Rates and independent

correlates of Pap smear testing among Korean-American women. Am J Public Health 1998;88(4):656-60.

95. Wismer BA, Moskowitz JM, Chen AM, Kang SH, Novotny TE, et al. Mammography and

clinical breast examination among Korean American women in two California counties. Prev Med 1998;14(1):19-24.

96. Flint AJ, Yamada EG, Novotny TE. Black-white differences in cigarette smoking uptake:

progression from adolescent experimentation to regular use. Prev Med 1998;27:358-364. 97. Novotny TE, Seward J, Sun R, Acree K. The Sausage Tour of Sacramento: an interactive

policy seminar for Preventive Medicine Residents and students. Am J Public Health 1999;89:771-773.

98. Berman SJ, Novotny TE. Extended degree and continuing education references of California

public health professionals. Jour Public Health Practice and Management May 1999;21-24. 99. Novotny TE, Jha P, Huffman SA, Nguyen SN. Tobacco control in the former Socialist

economies of Europe and Central Asia. Eurohealth Winter 1998/1999; 4:13-16. 100. Jha P, Novotny TE, Feachem R. The role of governments in tobacco control. In: The

Economics of Tobacco Control: Towards an Optimal Policy Mix. Abedian I, van der Merwe R, Wilkins N, and Jha P. eds. Cape Town, RSA: Applied Fiscal Research Centre, University of Capetown, 1999.

17

17

101. Novotny TE. Estimating smoking-attributable medical care costs: lessons from the US. In: The Economics of Tobacco Control: Towards and Optimal Policy Mix. Abedian I, van der Merwe R, Wilkins N, and Jha P. Ed. Cape Town, RSA: Applied Fiscal Research Centre, University of Capetown, 1999.

102. Novotny TE, Zhao F. Production and Consumption Waste: another externality of tobacco

use. Tobacco Control--An International Journal 1999;8:75-80. 103. Wismer BA, Chen AM, JunS, Kang SH, Lew R, Min K, Moskowitz JM, Novotny TE, Tager IB.

The Korean Breast and Cervical Cancer Screening Demonstration. In Kramer EJ, Ivery SL, Ying YW (Eds) Immigrant Women’s Health : Problems and Solutions. Jossey-Bass, San Francisco, California. Pp. 295-304, 1999.

104. Lightwood J, Collins D, Lapsley H., Novotny TE. Tobacco control in developing countries:

Estimating the costs of tobacco use in Prabhat Jha and Frank J. Chaloupka (eds.), Oxford University Press Inc., New York on behalf of The World Bank, 2000. pp 63-103

105. Novotny TE, Cohen JG, Yurekli A, Sweanor D, de Beyer J; Tobacco control in developing

countries: Smoking cessation and nicotine-replacement therapies in Prabhat Jha and Frank J. Chaloupka (eds.), Oxford University Press Inc., New York on behalf of The World Bank, 2000. pp 287-307.

106. Siegel M, Mowery PD, Pechacek TP, Strauss WJ, Schooley MW, Merritt RK, Novotny TE,

Giovino GA, Eriksen MP. Trends in adult cigarette smoking in California compared with the rest of the Untied States, 1978-1994. Am J Public Health 2000;90:372-379.

107. Novotny TE, Haazen D, Adeyi O. HIV/AIDS in Southeastern Europe—Case Studies from

Bulgaria, Croatia, and Romania. World Bank Working Paper No. 4. The World Bank Group: Washington, DC, 2003.

108. Adeyi O, Baris E, Novotny TE, et al. Averting AIDS Crises in Eastern Europe and Central

Asia: A Regional Support Strategy. The World Bank, Washington, DC, 2003. 109. McKee M, Gilmore A, Novotny TE. Smoke free hospitals: An achievable objective bringing

benefits for patients and staff. BMJ 2003; 326:941-942. 110. McKee M, Novotny TE. Political interference in American science—why Europe should be

concerned about the actions of the Bush administration. European J Public Health 2003;13:289-291.

111. Godinho J, Novotny TE, Tadesse H, Vinokur A. Central Asia HIV/AIDS and TB Country

Profiles. World Bank Working Paper No. 20. The World Bank, Washington, DC 2003. 112. Novotny TE and Fellows J. The Impact of Smoking on Disease and the Benefits of Smoking

Reduction (Chapter 7). In, USDHHS, The Health Consequences of Smoking: A Report of the Surgeon General. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2004.

113. Godinho J, Novotny T, et al. Southeastern Europe HIV/AIDS and TB Country Profiles. World

Bank, 2004. 114. Bozicevic I, Gilmore AB, Novotny TE. Tobacco use---a major public health issue in south-

18

18

east Europe. Eurohealth Winter 2003/2004; 9(4):1-4. 115. Levintova, M, Novotny, T. Non-communicable disease mortality in the Russian Federation:

from legislation to policy. Bulletin of the World Health Organization 2004;82:875-880. 116. Godinho J, Renton A, Vinogradov V, Novotny T, Gotsadze G, Rivers MJ, Bravo M.

Reversing the Tide: Priorities for HIV/AIDS Prevention in Central Asia. The World Bank, Working Paper No. 54, 2005.

117. Novotny TE, Carlin D. Ethical and Legal Aspects of Global Tobacco Control. Tob Control

2005;14:26-30. 118. Novotny TE. Commentary: AIDS is not just a transitional problem. BMJ 2005; 331:219. 119. Novotny TE. Why we need to re-think the diseases of affluence. PloS Medicine 2005;

2(5):0112-0113. 120. Novotny TE, Mordini E, Chadwick R, Pederson JM, Fabbri F, et al. (2006) Bioethical

implications of globalization: An international consortium project of the European Commission. PLoS Med 3(2): e43..

121. Yach D, McKee M, Lopez AD, Novotny T for Oxford Vision 2020. Improving diet and physical

activity: 12 lessons from controlling tobacco smoking. BMJ 2005;330;898-900. 122. Novotny TE (Book Review). Unfiltered: conflicts over tobacco policy and public health. New

Engl J Med 2005;352(20):2144-2145. 123. Rosenmöller, M, Novotny TE, Godinho J. HIV/AIDS at Europe’s eastern edge: Economic and

demographic challenges for health systems and disenfranchised populations. Eurohealth 2005;11(2):1-4.

124. Novotny TE. The US Public Broadcasting System and Time Magazine take on global health

(Reviews.). BMJ 2005;331:149. 125. Novotny TE. US Department of Health and Human Services: A Need for Global Health

Leadership in Preparedness and Health Diplomacy. Am J Public Health 2006;96(1):11-13. 126. Novotny T. Public health infrastructure and leadership for preparedness. In, Dios R, Lundy

D, Malia J (Eds.) Proceedings of the Global Health Summit, 2005. Washington, DC: George Washington University Department of Global Health, 2006.

127. Novotny TE. The “Ultimate Prize” for Big Tobacco: Opening the Chinese cigarette market by

cigarette smuggling. PLoS Med 2006;3(7): e279. DOI. 128. Begovac J, Lisić M, Lukas D, Maretić T, Kniewald T, Novotny TE. Marked improvement in

survival among adult Croatian AIDS patients after the introduction of highly active antiretroviral treatment. Coll Antropol. 2006 Mar;30(1):175-9.

129. Simic M, Johnston L, Platt L, Baros S, Andjelkovic V, Novotny T, Rhodes T. Exploring

barriers to ‘respondent driven sampling’ in sex worker and drug-injecting sex worker populations in Eastern Europe. Jour Urban Health 2006; 83(Suppl 7):6-15.

130. Novotny TE, Adams V. Global health diplomacy-A call for a new field of teaching and

19

19

research. San Francisco Medicine 2007;80(3):22-23. 131. Evert J, Novotny TE. International Health Diplomacy Examining the Cuban Model.

http://medschool.ucsf.edu/news/features/public_service/20070423_Cuba.aspx, April 23, 2007 132. Novotny TE. Global Health Education and Careers. In, Markle W, Fisher M, Smego R (eds.):

Understanding Global Health. New York, McGraw-Hill, 2007. 133. Kickbusch I, Novotny TE, Drager N., Silberschmidt G, Alcazar S. Global health diplomacy:

training across disciplines. Bulletin of WHO 2007, 85 (12):971-973. 134. Ho MG G, Shi Y, Ma SJ, Novotny TE. Perceptions of tobacco advertising and marketing that

might lead to smoking initiation among Chinese high school girls. Tobacco Control 2007 16: 359-360.

135. Novotny TE. Global governance and public health security in the 21st Century. California W

Internat Law Jour 2007;38(1):19-40. 136. Schneider NK, Novotny TE. Addressing smoking cessation in tuberculosis control Bulletin of

WHO 2007;85 (10):820-821. 137. Macfarlane SB; Agabian N PhD; Novotny TE; Rutherford, GW; Stewart, CC, Debas HT. Think

Globally, Act Locally, and Collaborate Internationally: Global Health Sciences at the University of California, San Francisco. Acad Med. 2008;83(2):173-179

138. Novotny TE. Smoking cessation and tuberculosis: connecting the DOTS. Int J Tuberc Lung Dis

2008;12:1103. 139. Zekan S, Novotny TE, Begovac J. Unsafe sexual behavior among HIV-infected patients in

Croatia, 2006: prevalence and associated factors. AIDS Behav 2008 Jul;12(4 Suppl):S86-92. 140. Novotny TE, Mamudu H. Progression of tobacco control policies: Lessons from the United

States and implications for global action. Health, Nutrition and Population (HNP) discussion paper, Washington DC: World Bank (May 1, 2008). http://siteresources.worldbank.org/HEALTHNUTRITIONANDPOPULATION/Resources/281627-1095698140167/NovotnyPoliticalEconomy.pdf

141. Novotny TE. Preventing chronic diseases: everybody’s business. In, Nolte E and McKee M.

Caring for People with Chronic Conditions: A Health System Perspective. Pp 92-115. Berkshire, England, Open University Press, 2008.

142. Novotny TE, Kickbusch I, Adams V, and Leslie H. Global Health Diplomacy--a Bridge to

Innovative Collaborative Action. Global Forum Update on Research for Health 2008;5;41-45 143. Adams V, Novotny TE, Leslie H. Global Health Diplomacy. Med Anthro 2008;27:315-323. 144. Yang JS, Novotny TE. (2009) Policy Coherence in US Tobacco Control: Beyond FDA

Regulation. PLoS Med 6(5): e1000079. doi:10.1371/journal.pmed.1000079 145. Finch K, Ma SJ, Qin DX, Xin G, Xia W, Novotny TE. Smoking knowledge, attitudes and

behaviors among rural-to-urban migrant women in Beijing, China. Asia-Pacific J Public Health, 2009. 2009 May 14. Epub ahead of print

20

20

146. Lim M, Novotny TE. A Case for Prioritizing Global Health Diplomacy Fed Practitioner

2009;26(3):10-13,23. 147. Turcinov D, Stanley C, Rutherford GW, Novotny TE, Begovac J. Adherence to the

Mediterranean diet is associated with a lower risk of body-shape changes in Croatian patients treated with combination antiretroviral therapy. Eur J Epidemiol DOI 10.1007/s10654-009-9330-2. Published online March 26, 2009.

148. Novotny T.E., Lum K., Smith E., Wang V., Barnes R. Cigarettes Butts and the Case for an

Environmental Policy on Hazardous Cigarette Waste. Internat J Environ Res Public Health. 2009; 6(5):1691-1705

149. Novotny TE. A vision of hope for US domestic and international health policy. Euro J Public

Health 2009;19(2):136-138. 150. Ho MG, Ma S, Chai W, Xia, W, Yang G, Novotny TE. Smoking Among Rural and Urban Young

Women in China. Tob Control tc.2009.030981Published Online First: 11 October 2009 doi:10.1136/tc.2009.030981

151. Shen S, Choi RY, Novotny TE. Economic sanctions towards North Korea: A violation of the

right to health and a call to action. BMJ 2009;339:b4069 152. Novotny TE, Smyser J. Global governance and biopreparedness for the United States. J

Biolaw & Bus 2009;12(3):25-30. 153. Lee K, Chagas LC, Novotny TE. Brazil and the framework convention on tobacco control: global

health diplomacy as soft power. PLoS Med 2010;7(4):e1000232. 154. Bloch M, Tong VT, Novotny TE, England LJ, Dietz PM, Kim SY, Samet JM, Tolosa JE. Tobacco

use and secondhand smoke exposure among pregnant women in low- and middle-income countries: a call to action. Acta Obstet Gynecol Scand. 2010 Apr;89(4):418-22.

155. Nichter M, Greaves L, Bloch M, Paglia M, Scarinci I, Tolosa JE, Novotny TE. Tobacco use and

secondhand smoke exposure during pregnancy in low- and middle-income countries: the need for social and cultural research. Acta Obstet Gynecol Scand. 2010 Apr;89(4):465-77.

156. Smyser J, Novotny TE. A vision revisited: Health Reform two years later. Eur J Public Health.

2010 Dec;20(6):614-5. 157. Shin SS, Lindsay RP, Robertson AM, Salgado H, Volkmann TA, Novotny TE, Barry DJ, Ivers

LC. Revisiting Alma-Ata in post-earthquake Haiti. BMJ.com Rapid Response. 2010. http://www.bmj.com/content/341/bmj.c3785/reply#bmj_el_239762?sid=580d079b-44a5-49ce-8b13-ec81f1c7d085.

158. Smith, Joshua R., Edland, Steven D., Novotny, Thomas E., Hofstetter, C. Richard, White,

Martha M., Lindsay, Suzanne P., Al-Delaimy, Wael K. Increasing hookah use in California Am J Public Health 2011 0: AJPH.2011.300196

159. Novotny TE, Hardin SN, Hovda LR, Novotny DJ, McLean MK, Khan S. Tobacco and cigarette butt consumption in humans and animals. Tob Control 2011;20:i17-i20 doi:10.1136/tc.2011.043489

21

21

160. Marah M, Novotny TE. Geographic patterns of cigarette butt waste in the urban environment. Tob Control 2011;20:i42-i44 doi:10.1136/tc.2010.042424

161. Smith EA, Novotny TE. Whose butt is it? tobacco industry research about smokers and cigarette butt waste. Tob Control 2011;20:i2-i9 doi:10.1136/tc.2010.040105

162. Sawdey M, Lindsay RP, Novotny TE. Smoke-free college campuses: no ifs, ands or toxic butts. Tob Control 2011;20:i21-i24 doi:10.1136/tc.2010.040139.

163. Slaughter E, Gersberg R, Watanabe K, Rudolf J, Novotny TE. Toxicity of Cigarette Butts, and their Chemical Components, to Marine and Freshwater Fish, Atherinops affinis and Pimephales promelas. Tob Control 2011;20:i25-i29 doi:10.1136/tc.2010.040170

164. Healton CG, Cummings KM, O’Connor RJ, Novotny TE. Butt really? The environmental impact of cigarettes. Tob Control 2011;20:i1 doi:10.1136/tc.2011.043729

165. Mamudu HM, Yang JS, Novotny TE. UN resolution on the prevention and control of non-communicable diseases: an opportunity for global action. Glob Public Health 2011;6(4):347-53.

166. Hawari FI, Bader RK, Beano HM, Obeidat MA, Ayub HS, Habesneh MA, Shtawei AS, Shihab RA, Madanat HM, Novotny TE. Perceptions of young Jordanian adults to proposed anti-tobacco pictorial warning labels. BMC Public Health 2011, 11:414doi:10.1186/1471-2458-11-414

167. Smith JR, Novotny TE, Edland SD, Hofstetter CR, Lindsay SP, Al-Delaimy WK. Determinants of hookah use among high school students. Nicotine Tob Res 2011;13(7):565-72.

168. Xia W, Shin SS, Wang Q, Raymond HF, Liu H, Ding D, Yang G, Novotny TE. Smoking among Young Rural to Urban Migrant Women in China: A Cross-Sectional Survey. PLoSOne 2011;6(8):1-7, e23028.

169. Balcius J, Novotny TE. New approaches to global health governance: The evolution to public–private partnerships. J Com Biotech 2011;17(3):

170. Shin S, Xiao D, Cao M, Wang C, Li Q, Chai W, Lindsay R, Usita P, Novotny TE. Patient and doctor perspectives of incorporating smoking cessation into tuberculosis care in Beijing, China. In press 2012, Int J Tuber Lung Dis

171. Lecours N, Almeida GEG, Abdallah JJ, Novotny TE. Environmental health impacts of tobacco farming: a review of the literature. Tob Control 2012 Mar;21(2):191-6.

172. Shin SS, Wan X, Wang Q, Raymond HF, Liu L, Ding D, Yang G, Novotny TE. Perceived discrimination and smoking among rural-to-urban migrant women in China. J Immigr Minor Health. 2012 Mar 3. [Epub ahead of print] doi 10.1007/s10903-012-9599-1.

173. Mackey KT, Liang BE, Novotny TE. Evolution of Tobacco Labeling and Packaging: Global Health Governance and International Legal Considerations. In press, Am J Public Health 2013

174. Shin SS, Gallardo M, Lozada R, Abramovitz D, Burgos JL, Laniado-Laborin R, Rodwell T, Novotny TE, Strathdee SA, Garfein RS. Cigarette smoking intensity and interferon gamma release assay conversion among persons who inject drugs: a cohort study. Pulm Med 2012: 828106. doi:10.1155/2012/828106.

175. Mackey KT, Novotny TE. Improving United Nations funding to strengthen global health governance: Amending the Helms-Biden Agreement. Global Governance 2012;VI(1): 1-19

176. Sereno AB, Soares ECC, Lapa e Silva JR, Nápoles AM, Bialous SA, da Costa e Silva VL, et al.

22

22

Feasibility study of a smoking cessation intervention in Directly Observed Therapy Short-Course tuberculosis treatment clinics in Rio de Janeiro, Brazil. Rev Panam Salud Publica. 2012;32(6):451–6.

BOOKS 1. 21st Century Health Diplomacy. Forthcoming 2013, World Scientific Publishers

PUBLISHED ABSTRACTS: 1. Novotny TE, Cohn DA, Thom D, et al. HIV infection in intravenous drug users in Denver:

Potential for decreasing transmission in a low prevalence area. Late Breaker Session, American Public Health Association Meeting, Las Vegas, Nevada, September 20, l986.

2. Novotny TE. Smoking and smokeless tobacco: What have we learned? Invited paper,

National Oral Health Conference. Mobile, Alabama, March 3l, l987. 3. Novotny TE and Young W. The Colorado plan for the control of tobacco. Society for

Behavioral Medicine Annual Meeting. May 20, l987. 4. Novotny TE, et al. Socioeconomic differences in smoking behavior in the United States.

American Public Health Association Meeting. October 19, l987. 5. Novotny TE, et al. Trends in smoking in the United States: Similarities between the races.

American Public Health Association Meeting. November l7, l988. 6. Novotny TE. The public health practice of tobacco control in the United States. International

Symposium on the Control of Tobacco-related Cancers and Other Diseases. Bombay, India, January 18, 1990.

7. Novotny TE. Smoking and health: developments of interest to the Family Physician. XVIthe

Annual Scientific Assembly and Academic Course. Uniformed Services Academy of Family Physicians, March 16, 1990.

8. Novotny TE. Progress and problems in tobacco control in the Americas. American Public

Health Association Annual Meeting, New York, 1990. 9. Novotny TE et al. Prevalence of Giardia lamblia in day-care and non-day-care attending

toddlers, Denver, Colorado, 1985. CDC Epidemic Intelligence Service Annual Conference, Atlanta, Georgia, 1986.

10. Novotny TE et al. Lead exposure in children of workers in a capacitor plant, Grand Junction,

Colorado 1984. CDC Epidemic Intelligence Service Annual Conference, Atlanta, GA, 1985. 11. Novotny TE et al. Smoking by blacks and whites in the United States: Socioeconomic

differences. CDC Epidemic Intelligence Service Annual Conference, Atlanta, GA, 1987. 12. Emont SL, Choi W, Novotny TE, Giovino GL, Davis RM. Statewide legislation, taxation, and

smoking behavior. CDC Epidemic Intelligence Service Annual Conference, Atlanta, Georgia, 1991

13. Rice DP, Max W., Novotny TE, Shultz JM, Hodgson, TA. The cost of smoking revisited.

APHA 120th Annual Meeting, Washington, DC--November 8-12, 1992. 14. Novotny TE, Choi W, Kendrick JS. A meta-analysis of smoking and spontaneous abortion.

8th World Conference on Tobacco or Health, Buenos Aires, Argentina, March 30-April 3,

23

23

1992. 15. Novotny TE. The public health practice of tobacco control: lessons learned and directions for

the states in the 1990s. 8th World Conference on Tobacco or Health, Buenos Aires, Argentina, March 30-April 3, 1992.

16. Novotny TE, Giovino GA. Smoking and poverty: another tough problem for the poor.

Society for Behavioral Medicine Fouteenth Annual Scientific Sessions, San Francisco, March 10-13, 1993.

17. Novotny TE et al. Teaching Public Health Practice: Tobacco Control. PREVENTION 93.

Poster Presentation, St. Louis MO, April 19, 1993. 18. Brownson RC, Matson DM, Novotny TE, Hughes RG, Eriksen MP. Environmental and Policy

Interventions for Public Health Action to Control Tobacco Use: Lessons Learned and Applications in Cardiovascular Disease Prevention. APHA 121st Annual Meeting. San Francisco, California, October 25, 1993.

19. Novotny TE, Healton C. Research linkages between academia and public health practice.

Prevention 94 "Science, Skills, and Strategies." The Eleventh Annual National Preventive Medicine Meeting, Atlanta, Georgia, March 19-22, 1994.

20. Novotny TE, Glynn T. Evaluation as a tool for the selection of priority activities. Ninth World

Conference on Tobacco and Health, Paris, France, October 13, 1994. 21. Novotny TE, Miller L, Bartlet J, et al. The economic costs of medical care attributable to

cigarette smoking, United States, 1993. Ninth World Conference on Tobacco and Health, Paris, France, October 13, 1994.

22. Novotny TE. The epidemiology of tobacco use and its health consequences: recent studies

on economics, policis, and behavior in the USA. First National Portuguese Epidemiology, Congress Porto, Portugal, October, 1996.

23. Flint AJ, Novotny TE. The impact of the change in definition of current smoking in the

National Health Interview Survey on smoking estimates for low socio-demographic groups. American Public Health Association Annual Meeting, New York, November 19, 1996.

24. Solanki G, Novotny, TE, Adams, K, Melvin, C. Up in Smoke: the Economic Burden of

Smoking (scientific session)--Pregnancy-related smoking costs. American Public Health Association Annual Meeting, New York, November 20, 1996.

25. Novotny TE. Integrating Public Health Into Health Systems Reform In the Eastern

European/Central Asia Region. World Conference on International Health Economics , San Francisco, Saturday, June 14, 2003.

26. Haazen DS, Novotny TE. Cost Effective Health Interventions in Latvia. Poster Presentation,

World Conference on International Health Economics , San Francisco, June 15, 2003. 27. Novotny TE. Environmental Interventions and Tobacco Use. Society for Epidemiologic

Research Annual Meeting, Atlanta, GA, June 13, 2003. 28. Novotny TE. The Roles of the State in Disease Control: Public Health. Third Russia Public

Health Seminar, Moscow, Russian Federation, April 23, 2003.

24

24

29. Novotny TE. Tobacco Control Policy: What Works. American College of Preventive Medicine

Annual Meeting, San Diego, California, February 20, 2003. 30. Novotny TE. The Global Tobacco Epidemic: An Ethical Perspective. Iowa Tobacco Control

Policy Seminar, Iowa City, Iowa, November 22, 2002. 31. Novotny TE. Globalization and Tobacco. The World Conference on Tobacco Or Health,

Helsinki, Finland, August 5, 2003. 32. Levintova M, Novotny TE. Tobacco Control Policy. US-Georgia Symposium “U.S.-Georgia

Biomedical Collaboration: Past Accomplishments, Current Status, and Future Regional Opportunities in the Caucasus". October 2003, Tbilisi, Georgia.

33. Novotny TE, Nunez D, Kennedy G. Asthma Prevention in Children: Clinical Practice and

Consumer Guidelines Development. ACPM Annual Meeting, Orlando Florida, February 20, 2004.

34. Hansen S, Novotny TE, Ruddick V. Comprehensive Curriculum in Global Health.

International Health Education Consortium Annual Meeting, February 17, 2004, Antigua, Guatemala.

35. Novotny TE. Are We There Yet? Upstream to Tobacco Control in the United States. STEP

UP to Tobacco Control: Advancing the Role of Public Health and Public Health Professionals. American Legacy Foundation, April 14-16, 2004, St. Louis, MO.

36. Novotny TH, Ruddick V, Hall TL, et al. A Comprehensive Curriculum in International Health.

AAMC Western Regional Meeting, April 20, 2004, Asilomar, CA. 37. Begovac J, Lisić M, Lukas D, Novotny TE , Skerlev M. Marked improvement in survival

following AIDS after introduction of highly active antiretroviral therapy (HAART) in adult patients from Croatia. "Bridges in Life Sciences": US-CEE Research Networking Meeting on HIV/AIDS and Related Conditions, October 14–16, 2004, Bucharest, Romania.

38. Novotny TE, Godinho J. HHIIVV//AAIIDDSS iinn EEaasstteerrnn EEuurrooppee PPoolliiccyy DDeevveellooppmmeenntt:: BBaarrrriieerrss &&

DDiirreeccttiioonnss ffoorr SSuucccceessss.. "Bridges in Life Sciences": US-CEE Research Networking Meeting on HIV/AIDS and Related Conditions, October 14–16, 2004, Bucharest, RomaniaGodinho J, Novotny TE. HIV/AIDS in Eastern Europe and Central Asia: The Necessary Public Health Response. “Global Health Challenges---European Approaches and Responsibilities”. European Health Forum Gastein. October 6-9, 2004, Gastein, Austria.

39. Choi R. Novotny TE. Pursuit of Health Diplomacy in North Korea. (Abstract). Global Health

Council Annual Meeting, Washington, DC, June 1, 2007. 40. Schneider NK, Novotny T, Araujo A, Bialous S, Durovni B, Sereno A, Lapa e Silva J.

Smoking Cessation in DOTS Clinics in Rio de Janeiro. (abstract) Society for Research on Nicotine and Tobacco (Latin America), annual meeting, Rio de Janeiro, 2007

41. Lum K, Novotny TE, Glantz S. Banning Butts: A Filterless Future (abstract). National

Conference on Tobacco or Health, Minneapolis, MN 2007. 42. Schneider NK, Novotny T, Araujo A, Bialous S, Durovni B, Sereno A, Lapa e Silva J.

Smoking Cessation in DOTS Clinics in Rio de Janeiro. (abstract). National Conference on

25

25

Tobacco or Health, Minneapolis, MN 2007 43. Novotny TE. Toxic, Hazardous Waste: Discarded Cigarette Filters. 14th World Conference

on Tobacco or Health, Mumbai, March 2009. 44. Novotny TE, Sereno A, Lapa e Silva JR, et a; A Pilot Study of Smoking Cessation in DOTS

Clinics, Rio de Janeiro. . 14th World Conference on Tobacco or Health, Mumbai, March 2009.

45. Novotny TE, Kickbusch I, Santos AL. Teaching and Learning Global Health Diplomacy.

Annual Meeting of the Consortium of Universities for Global Health, Bethesda, MD, Septermber 14-15, 2009.

46. Shin SS, Laniado-Laborin R, Lozada R, Cuevas-Mota J, Burgos JL, Rodwell TC, Novotny

TE, Garfein RS. Gender-specific association of smoking and latent tuberculosis infection among marginalized populations in Tijuana, Mexico. Paper presented at: The 15th Annual Conference of the International Union Against Tuberculosis and Lung Disease-North American Region; Feb 26, 2011; Vancouver, Canada.

47. Ding D, Wan X, Shin SS, Raymond HF, Liu H, Yang G, Novotny TE. Preventing smoking

initiation among rural-to-urban migrant women in China: Connecting a behavioral epidemiological study with policy discussions. 12th International Congress of Behavioral Medicine, Aug 30th, 2012. Budapest, Hungary

48. Cartwright J, Novotny TE. No Butts About It: Comprehensive Plan for Tackling Cigarette

Pollution. National Conference on Tobacco or Health, August 15, 2012, Kansas City, Missouri.

49. Lindsay R, Shin SS, Novotny T. Perceived causes of TB and TB treatment seeking behavior

among tobacco using women: DHS data from Lesotho and the Philippines. APHA Annual Meeting, October 27-31, 2012, San Francisco, California

50. Kurtz C, Cowling D, Novotny TE, Miller J. Evolution of Tobacco Waste Campaign from Local

to Statewide Efforts. APHA Annual Meeting, October 27-31, 2012, San Francisco, California

26